Nadolol in the treatment of central serous retinopathy.
Browning
D J
DJ
D000284:Administration, Oral; D000328:Adult; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009248:Nadolol / Q000009:adverse effects / Q000627:therapeutic use*; D011446:Prospective Studies; D012163:Retinal Detachment / Q000188:drug therapy*
D009248:Nadolol